Am-is, Maria Fe C.
HRN: 24 47 43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/31/2024
02/06/2024
IV
4.5gm
Q6
Septicemia
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes